<DOC>
	<DOCNO>NCT00212810</DOCNO>
	<brief_summary>The purpose study determine whether Topiramate effective preventing development chronic daily headache among patient episodic migraine headache .</brief_summary>
	<brief_title>Evaluation Effectiveness Topiramate Preventing Transformation From Episodic Migraine Chronic Daily Headache .</brief_title>
	<detailed_description>Chronic daily headache encompass frequent headache state increase burden pain compromise quality life adversely impact patient , family , health care provider . Approximately 5 % patient migraine , estimate 1.4 million Americans , manifest chronic daily headache form disease . The consequence include resistance treatment , worsen quality life , increase use use medication , development ischemic neuropathological brain lesion . This randomized , double-blind , placebo-controlled multicenter study enroll patient 18-65 year old establish history migraine headache , 28 day prior study migraine frequency least 10 less 15 migraine headache day per month , less 15 total headache day ( migraine plus non migraine headache ) per month . The study duration approximately 26 week . The study divide 4 phase follow : A Screening/Washout Phase may last 2-6 week , depend whether need stop take medication allow study ; A Baseline Phase last 4 week , time information collect migraine non-migraine headache experience period ; A double-blind Titration Phase last 4-6 week patient randomize treatment either Topiramate placebo . If randomize Topiramate , dose gradually increase dose either 75 100 mg day ; A Maintenance Period last 20 week time continue dose take completion Titration period ; Taper/Exit phase , last 2 week , gradually reduce dose study medication take study . The study hypothesis study drug effective placebo prevent patient transform episodic migraine chronic daily headache . Each patient ask record headache pain information medication use paper headache diary . Patients receive either Topiramate placebo . The number tablet topiramate placebo , gradually increase either minimum 3 tablets/day maximum 4 tablets/day . For Topiramate , 3 tablet would represent 75 mg 4 tablet would represent 100 mg/day .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine without Aura</mesh_term>
	<mesh_term>Migraine Aura</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>To qualify study must 1865 year old history migraine headache least 1 year experience least 10 less 15 migraine headache day less 15 total headache days/month able take oral medication able understand sign inform consent complete headache diary . You able participate study previously discontinue Topiramate make feel well make feel different migraine aura without headache positive urine drug screen history kidney stone history suicide attempt pregnant female already migraine preventive medicine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Headache</keyword>
	<keyword>Migraine Headache</keyword>
</DOC>